RX Bandz, Inc.
RX Bandz, Inc. received $5.8M in federal prime contract obligations in the 12 months ending Oct 5, 2026, up 117.7% from $2.6M the year before, and $17.6M since FY2022. Its largest customer is the Department of Defense.
See 1 contracts ending in the next 18 months ↓Contractor details
- Unique Entity ID (UEI)
- DXRED7S6FVE9
- CAGE code
- 7N2K8
- Headquarters
- Denville, NJ
- Business size
- Small Business
- Socioeconomic status
- WOSB
As recorded on this UEI's most recent prime contract action in USAspending.gov. Confirm current registration and certifications in SAM.gov.
Obligations by fiscal year
Net prime contract obligations by federal fiscal year.
Top agencies
Funding agencies ranked by obligations since FY2022.
| Funding agency | Latest 12 mo | Since FY2022 |
|---|---|---|
| Department of Defense | $5.8M | $17.6M |
Top NAICS codes
Industry codes agencies recorded on this contractor's awards, since FY2022.
| NAICS | Industry | Latest 12 mo | Since FY2022 |
|---|---|---|---|
| 541715 | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | $5.8M | $17.6M |
What it sells
Product and service codes (PSC) on this contractor's awards, since FY2022.
| PSC | Description | Since FY2022 |
|---|---|---|
| AA13 | Agriculture R&D services; Agricultural Research and services; Experimental Development | $11.7M |
| AC32 | National Defense R&D services; Defense-Related activities; Applied Research | $4.1M |
| AJ12 | General Science and Technology R&D services; General Science and technology; Applied Research | $1.8M |
Contracts ending in the next 18 months
This contractor's largest awards whose current period of performance ends soon. Options and extensions often move these dates.
| Award | Agency | Obligated | Current end |
|---|---|---|---|
| FA238424CB014 | Department of Defense TACTICAL INJECTOR KIT - HYDROMORPHONE | $5.1M | Sep 30, 2027 |
Recent awards
This contractor's newest prime contract awards, most recent first.
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| FA238424CB014 | Department of Defense TACTICAL INJECTOR KIT - HYDROMORPHONE | $1.2M | Sep 30, 2024 |
| FA238424CB013 | Department of Defense TACTICAL INJECTOR KIT - KETAMINE | $2.0M | Sep 24, 2024 |
| FA864923P1254 | Department of Defense SHELF-LIFE EXTENSION FOR EMERGENCY MEDICATION | $1.2M | Sep 28, 2023 |
| FA301623C0060 | Department of Defense MEDICAL RESEARCH AND DEVELOPMENT - SBIR II TACFI | $1.8M | Sep 16, 2023 |
| FA864923P0445 | Department of Defense STOP THE BLEED - SAVE THE WARFIGHTER! : INTRAMUSCULAR AUTO-INJECTOR DELIVERY OF TRANEXAMIC ACID (TXA) ON THE BATTLEFIELD | $1.2M | Feb 10, 2023 |
| FA864923P0216 | Department of Defense EXTENDED UTILIZATION OF LIFESAVING MEDICATIONS VIA AUTOINJECTOR | $75K | Nov 3, 2022 |
| FA864922P1153 | Department of Defense AUTO INJECTOR ADMINISTRATION OF KETAMINE FOR CRITICALLY INJURED AIRMEN | $750K | Jul 20, 2022 |
| FA864922P0661 | Department of Defense LIFE-SAVING MINI AUTO-INJECTOR TO DELIVER EPINEPHRINE | $750K | Jun 30, 2022 |
Prime contracts (award types A–D) from USAspending.gov through Oct 5, 2026. Subcontracts are not included. Net obligations include deobligations and corrections.
Ready to connect your pursuit work?
GovEagle gives BD directors, capture managers, and proposal teams one AI workspace from pipeline through proposal, with CMMC/FedRAMP Certified compliance built in.